{
  "id": "5a9d29571d1251d03b000018",
  "type": "factoid",
  "question": "What effect does azeliragon have on RAGE?",
  "ideal_answer": "Azeliragon is an inhibitor of receptor for advanced glycation end products (RAGE).",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/27678025"
  ],
  "snippets": [
    {
      "text": "Expert opinion: Drugs in Phase III clinical development for AD include one inhibitor of the \u03b2-secretase cleaving enzyme (BACE) (verubecestat), three anti-A\u03b2 monoclonal antibodies (solanezumab, gantenerumab, and aducanumab), an inhibitor of receptor for advanced glycation end products (RAGE) (azeliragon) and the combination of cromolyn sodium and ibuprofen (ALZT-OP1). ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27678025",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "Inhibitory"
}